Literature DB >> 20090858

Molecular Imaging of Myocardial Injury: A Magnetofluorescent Approach.

David E Sosnovik1.   

Abstract

The role of molecular imaging in enhancing the understanding of myocardial injury and repair is rapidly expanding. Moreover, in recent years magnetic resonance and fluorescence-based approaches have been added to the molecular imaging armamentarium and have been used to image selected molecular and cellular targets in the myocardium. Apoptosis, necrosis, macrophage infiltration, myeloperoxidase activity, cathepsin activity, and type 1 collagen have all been imaged in vivo with a magnetofluorescent (MRI and/or fluorescence) approach. This review highlights the potential of these and other magnetofluorescent agents, with particular focus on their role in ischemic heart disease.

Entities:  

Year:  2009        PMID: 20090858      PMCID: PMC2808047          DOI: 10.1007/s12410-009-0005-x

Source DB:  PubMed          Journal:  Curr Cardiovasc Imaging Rep        ISSN: 1941-9074


  37 in total

Review 1.  Shedding light onto live molecular targets.

Authors:  Ralph Weissleder; Vasilis Ntziachristos
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

2.  Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Jennifer R Allport; Si Chen; Ralph Weissleder; Paul L Huang
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

3.  Multiparameter magnetic relaxation switch assays.

Authors:  Sonia Taktak; David Sosnovik; Michael J Cima; Ralph Weissleder; Lee Josephson
Journal:  Anal Chem       Date:  2007-11-06       Impact factor: 6.986

Review 4.  Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications.

Authors:  David E Sosnovik; Matthias Nahrendorf; Ralph Weissleder
Journal:  Basic Res Cardiol       Date:  2008-03       Impact factor: 17.165

Review 5.  Noninvasive imaging of apoptosis in cardiovascular disease.

Authors:  Ethan Chauncey Korngold; Farouc Amin Jaffer; Ralph Weissleder; David Edwin Sosnovik
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

6.  Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart.

Authors:  E A Dumont; C P Reutelingsperger; J F Smits; M J Daemen; P A Doevendans; H J Wellens; L Hofstra
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

7.  Annexin-V imaging for noninvasive detection of cardiac allograft rejection.

Authors:  J Narula; E R Acio; N Narula; L E Samuels; B Fyfe; D Wood; J M Fitzpatrick; P N Raghunath; J E Tomaszewski; C Kelly; N Steinmetz; A Green; J F Tait; J Leppo; F G Blankenberg; D Jain; H W Strauss
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

8.  Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates.

Authors:  John W Chen; Manel Querol Sans; Alexei Bogdanov; Ralph Weissleder
Journal:  Radiology       Date:  2006-08       Impact factor: 11.105

9.  99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe.

Authors:  Ming Zhao; Zhixin Li; Scott Bugenhagen
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

10.  Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury.

Authors:  Matthias Nahrendorf; David Sosnovik; John W Chen; Peter Panizzi; Jose-Luiz Figueiredo; Elena Aikawa; Peter Libby; Filip K Swirski; Ralph Weissleder
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

View more
  2 in total

Review 1.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

2.  Molecular and Microstructural Imaging of the Myocardium.

Authors:  Shuning Huang; David E Sosnovik
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.